Maria Jose Perez Puerto

Title: Maria Jose Perez Puerto: Innovator in GSK-3 Inhibitors

Introduction

Maria Jose Perez Puerto is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of GSK-3 inhibitors. With a total of 2 patents, her work focuses on innovative solutions for diseases such as Alzheimer's and type II diabetes.

Latest Patents

Her latest patents include groundbreaking inventions related to urea derivatives and thiadiazolidine compounds. The first patent describes urea derivatives of formula (I) as inhibitors of glycogen synthase kinase 3β (GSK-3). This invention outlines processes for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating diseases where GSK-3 is involved, such as Alzheimer's disease and non-insulin dependent diabetes mellitus. The second patent provides details on thiadiazolidine compounds of formula I, which are selective GSK-3 inhibitors with improved bioavailability. These compounds are particularly useful for treating GSK-3 mediated diseases, including Alzheimer's disease, type II diabetes, depression, and brain injury.

Career Highlights

Throughout her career, Maria Jose has worked with notable companies in the pharmaceutical industry, including Neuropharma and Noscira. Her expertise and innovative approach have positioned her as a key player in the development of therapeutic solutions.

Collaborations

Maria Jose has collaborated with esteemed colleagues such as Ana Martinez Gil and Miguel Medina Padilla. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Maria Jose Perez Puerto is a distinguished inventor whose work on GSK-3 inhibitors has the potential to impact the treatment of several critical diseases. Her contributions to pharmaceutical innovation continue to pave the way for advancements in medical science.